Average Co-Inventor Count = 4.91
ph-index = 5
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Rapt Therapeutics, Inc. (12 from 13 patents)
2. Cleave Biosciences, Inc. (6 from 7 patents)
3. Xenoport, Inc. (4 from 142 patents)
4. H. Lundbeck A/s (2 from 506 patents)
5. Arbor Pharmaceuticals, LLC (2 from 20 patents)
6. Flx Bio, Inc. (2 from 2 patents)
7. Neurogastrx, Inc. (1 from 7 patents)
29 patents:
1. 12428393 - Methods of making trans isomeric forms of G protein-coupled receptor modulators
2. 12240837 - Chemokine receptor modulators and uses thereof
3. 12098139 - Chemokine receptor modulators and uses thereof
4. 12006318 - Crystalline forms of C-C chemokine receptor type 4 antagonist and uses thereof
5. 11918582 - Pyrazole pyrimidine compounds and uses thereof
6. 11384064 - Chemokine receptor modulators and uses thereof
7. 11192879 - Chemokine receptor modulators and uses thereof
8. 11084829 - Ubiquitin-specific-processing protease 7 (USP7) modulators and uses thereof
9. 11046699 - Pyrazolo-pyrimidin-amino-cycloalkyl compounds and their therapeutic uses
10. 10940117 - Oral dosage forms of methyl hydrogen fumarate and prodrugs thereof
11. 10722514 - Ubiquitin-specific-processing protease 7 (USP7) modulators and uses thereof
12. 10716760 - Oral dosage forms of methyl hydrogen fumarate and prodrugs thereof
13. 10683280 - Chemokine receptor modulators and uses thereof
14. 10604526 - Chemokine receptor modulators and uses thereof
15. 10246462 - Chemokine receptor modulators and uses thereof